The Mind Moments podcast features exclusive interviews with leaders in the field discussing
the latest research and disease management strategies across the breadth of neurology …

" The third piece—which is not new but interesting—there was this sense that providers were
not quite sure if they believed the results. Patients who they've had a long-standing …

The FDA's recent decision to convert lecanemab (Leqembi; Eisai), an antiamyloid therapy
indicated for early-stage Alzheimer disease (AD), opened the door for greater access and …

OBJECTIVE: To assess whether routine cognitive screening impacts dementia management
in a general neurology clinic. BACKGROUND: Cognitive screening with the MiniCog (MC) …

Objective: Conduct a pre-implementation assessment of barriers to performing cognitive
evaluations in primary care. Background: Early diagnosis is crucial to the optimal …

Background With the emergence of novel therapeutics, the importance of early identification
of people at risk of developing Alzheimer's disease is more critical than ever. Most …

Objective: In Germany, thousands of patients with MS (pwMS) are treated by neurologists in
private praxis. Although BICAMS (Brief International Cognitive Assessment for MS) was …

" It shows that you can get a very high positive predictive value that highlights the likelihood
of being a positive test, indicating AD pathology that is well above 90% and in some cases …

" It's those little things like latencies, initiation speed, termination speed ratios, like stroke
length, thinking, time processing, time placement, circularity. There's so many different …

Objective: We introduce the Mobile Toolbox Battery (MTB), a library of cognitive
assessments for at-home smartphone administration. It is designed for safe, remote, and …